Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Regression of choroidal neovascularization in response to systemic chemotherapy for cancer.

Hsu AW, Sodhi A, Eberhart C, Montaner S, Goldberg MF.

Can J Ophthalmol. 2013 Aug;48(4):e80-2. doi: 10.1016/j.jcjo.2013.02.004. No abstract available.

3.

Cisplatin and medium dose methotrexate in advanced transitional cell carcinoma of the urinary tract.

Fosså SD, Sager EM, Hosbach G, Waehre H, Ous S.

Scand J Urol Nephrol. 1990;24(3):199-204.

PMID:
2237296
4.

Successful treatment of transitional cell carcinoma of the urethra with chemotherapy.

VanderMolen LA, Sheehy PF, Dillman RO.

Cancer Invest. 2002;20(2):206-7. No abstract available.

PMID:
11901541
5.

Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma.

Sherif A.

Int Braz J Urol. 2007 Nov-Dec;33(6):840-1. No abstract available.

6.

The role of taxanes in the management of bladder cancer.

Galsky MD.

Oncologist. 2005 Nov-Dec;10(10):792-8. Review.

8.

[Combination chemotherapy with cisplatin and methotrexate in advanced bladder cancer].

Kobayashi K, Komatsu H, Takihana Y, Shirasu N, Tanabe N, Ishihama T, Takei K, Yamada Y, Ueno A.

Nihon Hinyokika Gakkai Zasshi. 1986 Jul;77(7):1182-7. Japanese. No abstract available.

PMID:
3784207
9.

Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.

Sternberg CN, Yagoda A, Scher HI.

Prog Clin Biol Res. 1988;277:45-51. No abstract available.

PMID:
3054909
10.

Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.

Adamo V, Magno C, Spitaleri G, Garipoli C, Maisano C, Alafaci E, Adamo B, Rossello R, Scandurra G, Scimone A.

Oncology. 2005;69(5):391-8. Epub 2005 Nov 24.

PMID:
16319510
11.

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, et al.

Cancer. 1989 Dec 15;64(12):2448-58.

12.

[Primary carcinoma of the female urethra].

Takahashi H, Hirano A, Nakano M, Tanaka K, Shinagawa T.

Hinyokika Kiyo. 1989 Nov;35(11):1943-5. Japanese.

13.

Haematological toxicity in patients treated with cisplatin and gemcitabine for bladder cancer: the Weston Park Hospital, Sheffield, experience.

Clenton SJ, Kirkbride P, Ferguson CJ.

Clin Oncol (R Coll Radiol). 2006 Oct;18(8):639. No abstract available.

PMID:
17051958
14.

Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.

Song YS, Cho JS, Cho KS, Doo SH, Chung BH, Kim SJ, Yang WJ, Song KH, Kim CI, Hong SJ.

Urol Int. 2010;85(1):47-51. doi: 10.1159/000296294. Epub 2010 Mar 16.

PMID:
20234122
15.

[Complete response of advanced bladder carcinoma to chemotherapy alone proved by histological examination of the surgical specimen: a case report].

Komatsu H, Kobayashi K, Takei K, Shirasu N, Tanabe N, Ishihama T, Yamada Y, Ueno A.

Nihon Hinyokika Gakkai Zasshi. 1985 Jan;76(1):116-20. Japanese. No abstract available.

PMID:
4040186
16.

Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB).

Sternberg CN, Skoneczna IA, Castellano D, Theodore C, Blais N, Voog E, Bellmunt J, Peters F, Le-Guennec S, Cerbone L, Risse ML, Machiels JP.

Oncology. 2013;85(4):208-15. doi: 10.1159/000354085. Epub 2013 Sep 24.

PMID:
24080920
17.
18.
19.

[Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].

Inoue T, Ohyama C, Horikawa Y, Togashi H, Matsuura S, Tsuchiya N, Satoh S, Sato K, Habuchi T, Saito S, Hoshi S, Arai Y, Kato T.

Hinyokika Kiyo. 2004 Apr;50(4):273-7. Japanese.

20.

A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.

Artz A, Stadler WM, Vogelzang NJ, Zimmerman T, Ryan C.

Am J Clin Oncol. 2005 Apr;28(2):109-13.

PMID:
15803001

Supplemental Content

Support Center